Affiliations 

  • 1 Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif 21947, Saudi Arabia
  • 2 School of Healthcare, University of Leicester, Leicester, LE1 7RH, United Kingdom
  • 3 School of Pharmacy, Queen's University Belfast, Belfast, BT7 1NN, United Kingdom
  • 4 Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, AB24 3FX, United Kingdom
  • 5 Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, 43600, Malaysia
  • 6 Department of General Practice and Primary Health Care, University of Auckland, Auckland, 1010, New Zealand
  • 7 Exeter Medical School, University of Exeter, Exeter, EX4 4PY, United Kingdom
  • 8 Discipline of Pharmacy, Faculty of Health, University of Canberra, Bruce, 2617, Australia
  • 9 Northumbria Healthcare NHS Trust and NHS, NE27 0QJ, United Kingdom
  • 10 School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, NR4 7TJ, United Kingdom
Int J Pharm Pract, 2024 Mar 06;32(2):180-185.
PMID: 38387608 DOI: 10.1093/ijpp/riae002

Abstract

BACKGROUND: Medication review (MR) is the systematic assessment of a patient's medications for safety and effectiveness by a healthcare professional. The language used to describe MR activity, such as stopped medicine and increased dose, should be consistent across studies to assist researchers compare how different services operate and identify their mechanism of impact.

AIM: To develop an international taxonomy of standardized terms and activity definitions related to medication reviews.

METHOD: This was a three-stage Delphi-based consensus study with international medication review experts. A systematic review provided MR activity terms for the survey. Experts rated their consensus on each activity term and its definition on a Likert scale and provided written feedback. The consensus was 75% panel agreement. At each stage, consensus elements were retained, and feedback was used to revise definitions.

RESULTS: Seven experts were recruited for the study (response rate 15.2%) from four countries: the United Kingdom (n = 4), New Zealand (n = 1), Australia (n = 1), and Malaysia (n = 1). The following terms achieved consensus: the term Medication as a descriptor for MR terms; discontinue medication, start medication, dose increase, dose decrease, dosage form change, and medication safety and efficacy monitor to describe MR activity; Educate to describe the delivery of healthcare professionals and patients/carers education.

CONCLUSION: Standardized medication review activity terms and definitions have been selected for universal adoption in all future MR research to facilitate a meaningful comparison of process evaluations within different settings.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.